HRP20060236A2 - Calcitonin gene related peptide receptor antagonists - Google Patents

Calcitonin gene related peptide receptor antagonists

Info

Publication number
HRP20060236A2
HRP20060236A2 HR20060236A HRP20060236A HRP20060236A2 HR P20060236 A2 HRP20060236 A2 HR P20060236A2 HR 20060236 A HR20060236 A HR 20060236A HR P20060236 A HRP20060236 A HR P20060236A HR P20060236 A2 HRP20060236 A2 HR P20060236A2
Authority
HR
Croatia
Prior art keywords
related peptide
treatment
peptide receptor
receptor
receptor antagonists
Prior art date
Application number
HR20060236A
Other languages
Croatian (hr)
Inventor
Chen Ling
Civiello Rita
P. Degnan Andrew
Gene
Han Xiaojun
Jun J. Jiang Xiang
Luo Guanglin
E. Macor John
Tora George
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/038799 external-priority patent/WO2005065779A1/en
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Priority to HR20060236A priority Critical patent/HRP20060236A2/en
Publication of HRP20060236A2 publication Critical patent/HRP20060236A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Predstavljeni izum se odnosi na Spojeve Formule (I), kao antagoniste receptora za peptid povezan sagenom za kalcitonin ("CGRP-receptor"), farmaceutske smjese koje ih sadrže, postupke za njihovu identifikaciju, postupke za liječenje njihovom primjenom i na njihovu primjenu u terapiji za liječenje neurogene vazodilatacije, neurogene upale, migrene i druge glavobolje, termalne povrede, cirkulatornog šoka, nastupa crvenila koje je povezano sa menopauzom, upalnih bolesti dišnih puteva, kao što su astma i kronična opstruktivna bolest pluća (COPD), kao i ostalih stanja čije se liječenje može postići preko antagonizma CGRP-receptora.The present invention relates to Compounds of Formula (I), as antagonists of the calcitonin sage-related peptide receptor ("CGRP-receptor"), pharmaceutical mixtures containing them, procedures for their identification, procedures for treatment using them and their use in therapy for the treatment of neurogenic vasodilatation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, inflammatory diseases of the respiratory tract, such as asthma and chronic obstructive pulmonary disease (COPD), as well as other conditions whose treatment can be achieved through CGRP-receptor antagonism.

HR20060236A 2003-12-05 2006-07-04 Calcitonin gene related peptide receptor antagonists HRP20060236A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HR20060236A HRP20060236A2 (en) 2003-12-05 2006-07-04 Calcitonin gene related peptide receptor antagonists

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/038799 WO2005065779A1 (en) 2003-12-05 2003-12-05 Calcitonin gene related peptide receptor antagonists
HR20060236A HRP20060236A2 (en) 2003-12-05 2006-07-04 Calcitonin gene related peptide receptor antagonists

Publications (1)

Publication Number Publication Date
HRP20060236A2 true HRP20060236A2 (en) 2006-10-31

Family

ID=37114582

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20060236A HRP20060236A2 (en) 2003-12-05 2006-07-04 Calcitonin gene related peptide receptor antagonists

Country Status (1)

Country Link
HR (1) HRP20060236A2 (en)

Similar Documents

Publication Publication Date Title
NO20062489L (en) Heterocyclic anti-migraine agents
NO20062648L (en) Calcitonin gene related peptide receptor antagonists
TW200407327A (en) Calcitonin gene related peptide receptor antagonists
NO20064888L (en) Heterocyclic CGRP antagonists for the treatment of migraine
TW200628470A (en) Constrained compounds as CGRP-receptor antagonists
EP2582432B1 (en) Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections
TN2012000139A1 (en) Cgrp receptor antagonists
CL2008001898A1 (en) Pyrazinone derived compounds, p38 inhibitors; process of preparing these; pharmaceutical composition comprising them; pharmaceutical combination comprising them; use to treat chronic obstructive pulmonary diseases and asthma.
WO2009126530A3 (en) Piperidine derivatives as cgrp receptor antagonists
EA201200876A1 (en) NEW ANTAGONISTS CCR2 RECEPTOR AND THEIR APPLICATION
CU23497A3 (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS
SE0200356D0 (en) Novel use
WO2007130860A3 (en) Constrained compounds as cgrp-receptor antagonists
EA201270751A1 (en) ANTAGONIST RECEPTOR CGRP
ATE517903T1 (en) COMPOUNDS WITH RESTRICTED CONFORMATION AS CGRP RECEPTOR ANTAGONISTS.
NO20084564L (en) Tight "Constrained" Compounds as CGRP Receptor Antagonists
UY30935A1 (en) COMBINATION: -ANTAGONIST OF THE CHEMIOQUINE RECEIVER 1 (CCR1) -AGONIST OF THE GLUCOCORTICOID RECEPTOR- OPTIONALLY AGONIST B (BETA) 2, - PHARMACEUTICAL COMPOSITION CONTAINING IT - APPLICATIONS.
NI200700039A (en) DERIVATIVES OF TRIAZOLOPIRIDINILSULFANILO AS QUINASA MAP P38 INHIBITORS.
EP2079725B1 (en) Piperidyl-propane-thiol ccr3 modulators
HRP20060236A2 (en) Calcitonin gene related peptide receptor antagonists
CA2667548A1 (en) Substituted piperidyl-propane-thiols
TH65848B (en) Resistor anthracite for calcitonin rylate peptide
TH78134A (en) Resistor anthracite for calcitonin rylate peptide
TH87766A (en) Heterocyclic anti-migraine agents
TH87766B (en) Heterocyclic anti-migraine agents

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20091204

Year of fee payment: 7

OBST Application withdrawn